Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.

Guido Dalbagni is an Urologist in New York, New York. Dr. Dalbagni is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy. Dr. Dalbagni is currently accepting new patients.

James Wysock is an Urologist in New York, New York. Dr. Wysock is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Urachal Cyst, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

Arjun Balar is an Oncologist in New York, New York. Dr. Balar is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Thrombectomy.

William Huang is an Urologist in New York, New York. Dr. Huang is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Shabnam A. Fidvi, MD, is an Attending Physician at Advanced Imaging at Montefiore Medical Park and Associate Professor of Radiology at Albert Einstein College of Medicine. Since joining the Montefiore team, her clinical focus has been abdominal imaging, including computed tomography (CT) and ultrasound modalities, and CT oncologic imaging, with a special interest in colorectal and pancreatic malignancies. Dr. Fidvi completed her medical school training at the University of Mumbai. She began her postgraduate training in Diagnostic Radiology at the University of Mumbai, B.Y.L. Nair Charitable Hospital. Following this, she completed a residency in Diagnostic Radiology at the New York Medical College, becoming Chief Resident in 2002. Dr. Fidvi went on to pursue a fellowship in Cross-Sectional Imaging at Thomas Jefferson University Hospital. Dr. Fidvi?s research focus on oncologic imaging expands from her clinical practice. Her work has been published in numerous peer-reviewed articles. She is active in teaching medical students and radiology residents and is a participant at weekly Tumor Board Conferences at Montefiore Einstein Cancer Center. Dr. Fidvi is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Neuroendocrine Tumor, WT1-Related Wilms Tumor Syndromes, Ureterocele, and Progressive Familial Intrahepatic Cholestasis Type 3.

Robert Berkenblit, MD, FACR, is Associate Medical Director at the Montefiore Imaging Center and Associate Professor of Radiology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 1996, his clinical interests include utilizing CT scans, ultrasound, and MRIs to evaluate the abdomen and pelvis, particularly the genitourinary system and the adrenal glands. He also has a special interest in utilizing an open MRI system to evaluate the abdomen and pelvis. Dr. Berkenblit is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Visceromegaly, WT1-Related Wilms Tumor Syndromes, Chronic Cough, and Ureterocele.

Alexander I. Sankin, MD, is Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer. Dr. Sankin is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy.

Arie Franco, MD, PhD, is an attending radiologist at Montefiore Einstein and Associate Professor, Radiology at our Albert Einstein College of Medicine. Dr. Franco’s clinical focus centers on cardiothoracic imaging, particularly in cardiac pathology in pediatric and adult populations. He is also interested in adult congenital heart disease and chest oncology. Dr. Franco is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pleurisy, Pleural Effusion, Emphysema, and Schizencephaly.

Jana Fox is a Radiation Oncologist in Bronx, New York. Dr. Fox is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Breast Cancer, Angiosarcoma, Laryngeal Cancer, and Throat Cancer.

John Amodio, MD, FACR, is Chief, Radiology and Division Lead, Pediatric Radiology at Children’s Hospital at Montefiore Einstein and Professor, Radiology at our Albert Einstein College of Medicine. Dr. Amodio has 40 years of experience in pediatric imaging. His particular interest is the use of contrast ultrasound in pediatric imaging. Dr. Amodio is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Gas Bloat Syndrome, Schizencephaly, Porencephaly, and Tracheobronchopathia Osteoplastica.

Ahmed Aboumohamed, MD is an Attending Physician and a Professor in the Department of Urology at Montefiore and our Albert Einstein College of Medicine. Dr. Aboumohamed's areas of expertise include urology, urologic oncology, minimally invasive and robotic surgery, and urologic reconstruction. Dr. Aboumohamed is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bilateral Hydronephrosis, Bladder Cancer, Hydronephrosis, Cystectomy, and Nephrectomy.

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Caroline Hwang is a Hematologist Oncology specialist and a Hematologist in Bronx, New York. Dr. Hwang is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Colorectal Cancer.

Mark Stein is an Oncologist and a Hematologist in New York, New York. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy.

James Mckiernan is an Urologist in New York, New York. Dr. Mckiernan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Marc Janis is an Urologist in Mount Vernon, New York. Dr. Janis is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Eunuchoidism Familial Hypogonadotropic, Male Pseudohermaphroditism with Gynecomastia, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

Abraham Chachoua is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Chachoua is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma.

Michael Stifelman is an Urologist in Hackensack, New Jersey. Dr. Stifelman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), UPJ Obstruction, Retroperitoneal Fibrosis, Nephrectomy, and Ureteral Reconstruction.

Robert Alter is an Otolaryngologist in Hackensack, New Jersey. Dr. Alter is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.